These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23001148)

  • 21. [Safety and efficacy of growth hormone treatment: GeNeSIS study in Spain].
    Luzuriaga Tomás C; Oyarzabal Irigoyen M; Caveda Cepas E; Vázquez Salvi LA; García-Pérez LE;
    An Pediatr (Barc); 2016 Mar; 84(3):139-47. PubMed ID: 26139238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GH treatment to final height produces similar height gains in patients with SHOX deficiency and Turner syndrome: results of a multicenter trial.
    Blum WF; Ross JL; Zimmermann AG; Quigley CA; Child CJ; Kalifa G; Deal C; Drop SL; Rappold G; Cutler GB
    J Clin Endocrinol Metab; 2013 Aug; 98(8):E1383-92. PubMed ID: 23720786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential for Optimization of Growth Hormone Treatment in Children with Growth Hormone Deficiency, Small for Gestational Age, and Turner Syndrome in Germany: Data from the PATRO® Children Study.
    Partsch CJ; Land C; Pfäffle RW; Schwab KO; Sommer H;
    Horm Res Paediatr; 2024 Apr; ():1-11. PubMed ID: 38663373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant growth hormone therapy in children with Turner Syndrome in Korea: a phase III Randomized Trial.
    Kim J; Kim MS; Suh BK; Ko CW; Lee KH; Yoo HW; Shin CH; Hwang JS; Kim HS; Chung WY; Kim CJ; Han HS; Jin DK
    BMC Endocr Disord; 2021 Dec; 21(1):243. PubMed ID: 34893062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implications of a data-driven approach to treatment with growth hormone in children with growth hormone deficiency and Turner syndrome.
    Kaspers S; Ranke MB; Han D; Loftus J; Wollmann H; Lindberg A; Roelants M; Kleintjens J
    Appl Health Econ Health Policy; 2013 Jun; 11(3):237-49. PubMed ID: 23649890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resting energy expenditure in girls with Turner syndrome.
    Binder G; Frank L; Ziegler J; Blumenstock G; Schweizer R
    J Pediatr Endocrinol Metab; 2017 Mar; 30(3):327-332. PubMed ID: 28236628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Body proportions during long-term growth hormone treatment in girls with Turner syndrome participating in a randomized dose-response trial.
    Sas TC; Gerver WJ; de Bruin R; Stijnen T; de Muinck Keizer-Schrama SM; Cole TJ; van Teunenbroek A; Drop SL
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4622-8. PubMed ID: 10599729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth and Adult Height in Girls With Turner Syndrome Following IGF-1 Titrated Growth Hormone Treatment.
    Cleemann Wang A; Hagen CP; Nedaeifard L; Juul A; Jensen RB
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32421787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adult height after growth hormone treatment in Japanese children with idiopathic growth hormone deficiency: analysis from the KIGS Japan database.
    Fujieda K; Tanaka T; Takano K; Chihara K; Seino Y; Irie M;
    J Pediatr Endocrinol Metab; 2011; 24(7-8):457-62. PubMed ID: 21932582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Basal characteristics and first year responses to human growth hormone (GH) vary according to diagnostic criteria in children with non-acquired GH deficiency (naGHD): observations from a single center over a period of five decades.
    Ranke MB; Schweizer R; Binder G
    J Pediatr Endocrinol Metab; 2018 Nov; 31(11):1257-1266. PubMed ID: 30332395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of growth hormone on cognitive function.
    Ross JL
    Horm Res; 2005; 64 Suppl 3():89-94. PubMed ID: 16439850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacogenomics of insulin-like growth factor-I generation during GH treatment in children with GH deficiency or Turner syndrome.
    Stevens A; Clayton P; Tatò L; Yoo HW; Rodriguez-Arnao MD; Skorodok J; Ambler GR; Zignani M; Zieschang J; Della Corte G; Destenaves B; Champigneulle A; Raelson J; Chatelain P
    Pharmacogenomics J; 2014 Feb; 14(1):54-62. PubMed ID: 23567489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The response to growth hormone treatment in prepubertal children with growth hormone deficiency in Japan: Comparing three consecutive years of treatment data of The Foundation for Growth Science in Japan between the 1990s and 2000s.
    Isojima T; Hasegawa T; Yokoya S; Tanaka T
    Endocr J; 2017 Sep; 64(9):851-858. PubMed ID: 28679975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of growth hormone therapy on Taiwanese children with growth hormone deficiency.
    Huang YH; Wai YY; Van YH; Lo FS
    J Formos Med Assoc; 2012 Jul; 111(7):355-63. PubMed ID: 22817812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth hormone and low dose estrogen in Turner syndrome: results of a United States multi-center trial to near-final height.
    Quigley CA; Crowe BJ; Anglin DG; Chipman JJ
    J Clin Endocrinol Metab; 2002 May; 87(5):2033-41. PubMed ID: 11994337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IGF-I and IGF-binding protein-3 measurements on filter paper blood spots in children and adolescents on GH treatment: use in monitoring and as markers of growth performance.
    Das U; Whatmore AJ; Khosravi J; Wales JK; Butler G; Kibirige MS; Diamandi A; Jones J; Patel L; Hall CM; Price DA; Clayton PE
    Eur J Endocrinol; 2003 Sep; 149(3):179-85. PubMed ID: 12943519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Real-life GH dosing patterns in children with GHD, TS or born SGA: a report from the NordiNet® International Outcome Study.
    Blankenstein O; Snajderova M; Blair J; Pournara E; Pedersen BT; Petit IO
    Eur J Endocrinol; 2017 Aug; 177(2):145-155. PubMed ID: 28522645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth hormone therapy is associated with improved uterine dimensions in girls with Turner syndrome prior to oestrogen replacement.
    Mondal S; Gargari P; Nagendra L; Mandal S; Kumar RC; Shah P; Haldar M; Chowdhury S; Mukhopadhyay S
    Clin Endocrinol (Oxf); 2024 Jan; 100(1):66-75. PubMed ID: 37555570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating IGF-I, IGFBP-3 and the IGF-I/IGFBP-3 Molar Ratio Concentration and Height Outcome in Prepubertal Short Children on rhGH Treatment over Two Years of Therapy.
    Ballerini MG; Braslavsky D; Scaglia PA; Keselman A; Rodríguez ME; Martínez A; Freire AV; Domené HM; Jasper HG; Bergadá I; Ropelato MG
    Horm Res Paediatr; 2017; 88(5):354-363. PubMed ID: 28926833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term safety and effectiveness of growth hormone therapy in Korean children with growth disorders: 5-year results of LG Growth Study.
    Rhie YJ; Yoo JH; Choi JH; Chae HW; Kim JH; Chung S; Hwang IT; Shin CH; Kim EY; Kim HS
    PLoS One; 2019; 14(5):e0216927. PubMed ID: 31095622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.